MedPath

Clinical re evaluation and application transformation of traditional Chinese medicine in the treatment of difficult skin diseases

Phase 2
Conditions
Psoriasis
Registration Number
ITMCTR2200005536
Lead Sponsor
Xinjiang Institute of Traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

? Patients with spleen deficiency and dampness excess syndrome of psoriasis vulgaris were definitely diagnosed;
? Age 18 ~ 70 years old;
? The course of disease was 0 ~ 20 years;
? Informed consent, voluntary treatment, observation and examination.

Exclusion Criteria

? Arthritis type, pustular type, erythroderma type psoriasis;
? Systematic treatment within 3 months, including large-area topical use of powerful cortical sterols or immunosuppressants;
? Patients with serious primary diseases or psychosis such as cardio cerebrovascular, liver and kidney and hematopoietic system;
? Pregnant, pregnant or lactating women;
? Those who fail to use drugs according to regulations, cannot judge the curative effect, or incomplete data affect the judgment of curative effect or safety.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
PASI;Recurrence rate of psoriasis;
Secondary Outcome Measures
NameTimeMethod
VAS;Dosage of Western medicine for external use;SDS;Onset time;rebound rate;time to relapse;DLQI;SAS;BSA;
© Copyright 2025. All Rights Reserved by MedPath